SeaStar Medical Holding Corp ICU.OQ ICU.O is expected to show a rise in quarterly revenue when it reports results on March 25 for the period ending December 31 2025
The Denver Colorado-based company is expected to report a 456.0% increase in revenue to $372.5 thousand from $67 thousand a year ago, according to the mean estimate from 2 analysts, based on LSEG data.
LSEG's mean analyst estimate for SeaStar Medical Holding Corp is for a loss of $1.06 per share.
The one available analyst rating on the shares is "buy".
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for SeaStar Medical Holding Corp is $9.00, about 303.6% above its last closing price of $2.23
This summary was machine generated March 23 at 20:27 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Comments